RIT1驱动瘤转化,是肺腺癌的可操作目标
Alessandro M Mozzarelli1, Antonio Cuevas-Navarro2, Emily G Shuldiner3
1Department of Biochemistry and Molecular Pharmacology, NYU Grossman School of Medicine, New York, New York.
Cancer research
|July 11, 2025
概括
在RIT1基因突变驱动肺癌通过增加蛋白质水平和失调信号通路. 由RIT1驱动的瘤对向治疗有反应,包括RAS三复合抑制剂,提供了一种新的治疗策略.
科学领域:
- 在瘤学瘤学.
- 分子生物学分子生物学
- 遗传学 遗传学 是一个
背景情况:
- RIT1是一种RAS家族的GTPase,与肺癌,白血病和努南综合征有关.
- 通过受损的蛋白质分解,RIT1突变增加了蛋白质水平,破坏了RAS/MAPK信号传递.
- RIT1充当瘤基因,促进肺部瘤发生.
研究的目的:
- 研究人类肺癌中RIT1突变的多样性.
- 在体内评估RIT1突变的致癌潜力.
- 评估针对RIT1或下游途径的治疗策略.
主要方法:
- 在人类肺癌中记录了RIT1突变多样性.
- 利用小鼠模型研究RIT1 M90I驱动的肺瘤发展.
- 评估了直接的RIT1抑制和下游RAS/MAPK通路的抑制.
- 采用化学生物学来识别针对RIT1.1的RAS三复合抑制剂.
主要成果:
- 在体内,RIT1 M90I的生理表达驱动着本土肺瘤的发展.
- RIT1 M90I瘤对SHP2抑制剂和RAS核酸交换抑制剂敏感.
- 拉斯三复合抑制剂与GTP结合的RIT1结合,导致瘤缩.
结论:
- 在肺癌中,RIT1是真正的瘤基因.
- 用RAS三复合抑制剂直接向RIT1是一种可行的治疗方法,用于RIT1驱动的肺瘤.
更多相关视频
06:03Orthotopic Transplantation of Syngeneic Lung Adenocarcinoma Cells to Study PD-L1 Expression
Published on: January 19, 2019
17.3K
13:34A Combined 3D Tissue Engineered In Vitro/In Silico Lung Tumor Model for Predicting Drug Effectiveness in Specific Mutational Backgrounds
Published on: April 6, 2016
10.3K
相关概念视频
Abnormal Proliferation
4.6K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.6K
The Retinoblastoma Gene
4.2K
Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
4.2K
Targeted Cancer Therapies
7.8K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.8K
lncRNA - Long Non-coding RNAs
9.0K
In humans, more than 80% of the genome gets transcribed. However, only around 2% of the genome codes for proteins. The remaining part produces non-coding RNAs which includes ribosomal RNAs, transfer RNAs, telomerase RNAs, and regulatory RNAs, among other types. A large number of regulatory non-coding RNAs have been classified into two groups depending upon their length – small non-coding RNAs, such as microRNA, which are less than 200 nucleotides in length, and long non-coding RNA...
9.0K
The Ras Gene
6.4K
The Ras-gene-encoded proteins are regulators of signaling pathways controlling cell proliferation, differentiation, or cell survival. The Ras-gene family in humans constitutes three primary members—the HRas, NRas, and KRas. These genes code for four functionally distinct yet closely related proteins—the HRas, NRas, KRas4A, and KRas4B. The involvement of mutant Ras genes in human cancer was first discovered in 1982 and is among the most common causes of human tumorigenesis.
Ras is a...
Ras is a...
6.4K
mTOR Signaling and Cancer Progression
3.9K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
3.9K
